Parjanya Bhatt

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy

K. Sharma, Ashwati Konat, Aditya Shah, 2022, Frontiers in Cardiovascular Medicine.

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease

Aditya S. Shah, Ashwati Konat, Shalini Rawal, 2022, Frontiers in Cardiovascular Medicine.

Over the counter drugs and self-medication: A worldwide paranoia and a troublesome situation in India during the COVID-19 pandemic

M. M. Hasan, E. Khan, Sarya Swed, 2022, Annals of Medicine and Surgery.

Emerging zoonotic diseases and COVID-19 pandemic: global Perspective and Indian Scenario

M. Bardhan, A.Subha Shree, I. Ray, 2023, Annals of medicine and surgery.